Document is current
Any future updates will be listed below
-
Authors
Wang, Chen-Yi
Philpott, Martin
P O’Brien, Darragh https://orcid.org/0000-0003-4924-7795
Ndungu, Anne
Malzahn, Jessica
Maritati, Marina
Mehta, Neelam
Gamble, Vicki
Martinez-Burgo, Beatriz https://orcid.org/0000-0002-5357-4556
Bonham, Sarah
Fischer, Roman https://orcid.org/0000-0002-9715-5951
Garbutt, Kurtis https://orcid.org/0000-0001-9543-2110
Becker, Christian M. https://orcid.org/0000-0002-9870-9581
Manek, Sanjiv
Harris, Adrian L. https://orcid.org/0000-0003-1376-8409
Sacher, Frank
Obendorf, Maik
Schmidt, Nicole
Müller, Jörg https://orcid.org/0000-0001-6295-1221
Zollner, Thomas M.
Zondervan, Krina T. https://orcid.org/0000-0002-0275-9905
Kessler, Benedikt M. https://orcid.org/0000-0002-8160-2446
Oppermann, Udo https://orcid.org/0000-0001-9984-5342
Cribbs, Adam P. https://orcid.org/0000-0001-5288-3077
-
Funding
Funding for this research was provided by:
RCUK | Medical Research Council (MR/V010182/1)
Wellcome Trust (097812/Z/11/Z)
RCUK | Engineering and Physical Sciences Research Council (EP/N034295/1)
- License Information
-
More Information
Article History
Received: 27 May 2024
Accepted: 18 July 2025
First Online: 31 July 2025
Competing interests
: FS, MO, NS, JM, and TMZ are employees and shareholders of Bayer Pharmaceuticals. MP, APC and UO are co-founders of Caeruleus Genomics plc. The study was jointly supported by Oxford and Bayer Healthcare; conceptualisation, research, data analysis and presentation were conducted in an unbiased manner and not influenced by the funding bodies.
